COVID-19
Regístrese
Clínica e Investigación en Ginecología y Obstetricia
Suscribe to the journal
Buscar en
Clínica e Investigación en Ginecología y Obstetricia
Toda la web
Inicio Clínica e Investigación en Ginecología y Obstetricia Comparación de clobetasol frente a prednicarbato para el tratamiento del prurit...
Journal Information
Previous article | Next article
Vol. 30. Issue 4.
Pages 104-117 (January 2003)
Export reference
Share
Share
Print
Download PDF
More article options
Statistics
Vol. 30. Issue 4.
Pages 104-117 (January 2003)
DOI: 10.1016/S0210-573X(03)77241-4
Full text access
Comparación de clobetasol frente a prednicarbato para el tratamiento del prurito vulvar con o sin distrofia
Visits
18629
Download PDF
Estudio preliminar, prospectivo de un año, J. López-Olmos
This item has received
18629 Visits
Article information
Abstract
Bibliography
Download PDF
Statistics
Summary

We present a clinical, prospective and comparative study over one year, between two topical corticosteroids in the treatment of vulvar pruritus, with or without dystrophy. Clobetasol versus prednicarbate, with 10 cases in both groups.

The results were very good, with improvement of the pruritus in all cases. Those cases of vulvar dystrophy with lichen sclerosus type lesions also improved. There were no secondary effects.

In conclusion, both products are efficacious in the treatment of vulvar pruritus, and vulvar dystrophy also improves.

Resumen

Presentamos un estudio clínico prospectivo y comparativo de un año entre dos corticoides tópicos para el tratamiento del prurito vulvar con y sin distrofia vulvar, clobetasol frente a prednicarbato, con 10 casos en cada grupo.

Los resultados han sido muy buenos, desapareciendo el prurito en todos los casos. Los casos de distrofia vulvar tipo liquen escleroatrófico (LEA) también mejoraron de las lesiones. No hubo efectos secundarios.

Como conclusión, ambos productos son eficaces para tratar el prurito vulvar, y la distrofia vulvar también mejora.

Full text is only aviable in PDF
Bibliografía
[1.]
N. Jeffcoate.
Ginecología. Buenos.
[2.]
LJ. Margesson.
Vulvovaginal dryness and itching.
Skin Ther Lett, 6 (2001), pp. 3-4
[3.]
BL Harlow, LA Wise, EG. Stewart.
Prevalence and predictors of chronic lower genital tract discomfort.
Am J Obstet Gynecol, 185 (2001), pp. 545-550
http://dx.doi.org/10.1067/mob.2001.116748 | Medline
[4.]
EA Olsen, RC. Cornell.
Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
J Am Acad Dermatol, 15 (1986), pp. 246-255
Medline
[5.]
CC Otley, A. Sober.
Over the counter clobetasol propionate [letter].
Arch Dermatol, 130 (1994), pp. 121
Medline
[6.]
FM Keane, SE Munn, NF Taylor, Vivier AWP. Du.
Unregulated use of clobetasol propionate [letter].
Br J Dermatol, 144 (2001), pp. 1095-1096
Medline
[7.]
F Scrimin, S Rustj, O Radillo, C Volpe, R Abrami, S. Guashi-no.
Vulvar lichen sclerosus: an immunologic study.
Obstet Gynecol, 95 (2000), pp. 147-150
Medline
[8.]
KL Dalziel, PR Millard, F. Wojnarowska.
The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0,05%) cream.
Br J Dermatol, 124 (1991), pp. 461-464
Medline
[9.]
P Carli, A Cattaneo, B. Giannotti.
Clobetasol propionate 0,05% cream in the treatment of vulval lichen sclerosus: effect on the immunohistological profile [letter].
Br J Dermatol, 127 (1992), pp. 542-543
Medline
[10.]
KL Dalziel, F. Wojnarowska.
Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream.
J Reprod Med, 38 (1993), pp. 25-27
Medline
[11.]
GL Bracco, P Carli, L Sonni, G Maestrini, A De Marco, GL Taddei, et al.
Clinical and histological effects of topical treatments of vulval lichen sclerosus.
J Reprod Med, 38 (1993), pp. 37-40
Medline
[12.]
A Cattaneo, P Carli, A de Marco, L Sonni, GL Bracco, A de Magni, et al.
Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.
J Reprod Med, 41 (1996), pp. 99-102
Medline
[13.]
B Lorenz, RH Kaufmann, SK. Kutzner.
Lichen sclerosus.Therapy with clobetasol propionate.
J Reprod Med, 43 (1998), pp. 790-794
Medline
[14.]
J Bornstein, S Heitetz, Y Kellner, Z Stolar, H. Abramovici.
Clobetasol dipropionate 0,05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus.
Am J Obstet Gynecol, 178 (1998), pp. 80-84
Medline
[15.]
P Sinha, O Sorinola, DM. Luesley.
Lichen sclerosus of the vulva. Long-term steroid maintenance therapy.
J Reprod Med, 44 (1999), pp. 621-624
Medline
[16.]
YR Smith, EH. Quint.
Clobetasol propionate in the treatment of premenarcheal vulvar lichen sclerosus.
Obstet Gynecol, 98 (2001), pp. 588-591
Medline
[17.]
F. Schröpl.
Klinische studien mit prednicarbat unter besonderer beürcksochtigung der doppelblindvergbeiche zu therapieülbichen präparaten.
Z Hautkr, 61 (1985), pp. 80-87
Medline
[18.]
R Hein, Krieg TH. y.
Effects of corticosteroids on human fibroblasts in vitro.
Topical corticosteroid therapy: a novel approach to safer drugs, pp. 57-65
[19.]
PD Dykes, S Hill, R. Marks.
Assesment of the atrophogenicity potential of corticosteroids by ultrasound and by epidermal biopsy under occlusive and non occlusive conditions.
Topical corticosteroid therapy: a novel approach to safer drugs, pp. 111-118
[20.]
F Schröpl, Ch. Schubert.
Long-term study on local steroids using the example of prednicarbate.
Christophers E, pp. 155-167
[21.]
J Dehavay, GE Piérard, ChM. Lapière.
Evaluation of the potential atrophogenicity of 0,25% prednicarbate cream.
Topical corticosteroid therapy: a novel approach to safer drugs, pp. 119-125
[22.]
A Stary, H. Tronnier H. Schulz.
Ekzemkrankheiter und erythematosquamöse dermatosen der altershaut Untersuchungen zur wirksamkeit und verträglichkeit von prednicarbat in verschiedenen zuberistrungsformen.
Z Hautkr, 64 (1989), pp. 1010-1014
Medline
[23.]
JR Bjerke, BT Gjertsen, LE. Peterson.
Prednicarbate (Der-matop) compared with desoximethasone (Ibaril). A double-blind clinical trial of a non-halogenated corticosteroid in 57 patients with psoriasis.
Clin Trials J, 27 (1990), pp. 94-99
[24.]
G. Albrecht.
Clinical comparison of methylprednisolone aceponate and prednicarbate in chronic eczema.
J Eur Acad Dermatol Venereol, 3 (1994), pp. S42-S48
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados

Subscribe to our newsletter

Publish in
Clínica e Investigación en Ginecología y Obstetricia
Special content about COVID-19
Recommended
articles
Detección de ITS (infecciones de trasmisión sexual) en...
Clin Invest Ginecol Obstet 2019;46:115-21

Clínica e Investigación en Ginecología y Obstetricia follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
Detección de ITS (infecciones de trasmisión sexual) en mujeres afectas de ASCUS y LSIL en la citología cervicovaginal. Estudio prospectivo de 4 meses
10.1016/j.gine.2019.02.003
No mostrar más